Pinnacle Wealth Planning Services Inc. Decreases Stock Position in Zoetis Inc. $ZTS

Pinnacle Wealth Planning Services Inc. decreased its position in shares of Zoetis Inc. (NYSE:ZTS) by 11.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,581 shares of the company’s stock after selling 471 shares during the period. Pinnacle Wealth Planning Services Inc.’s holdings in Zoetis were worth $558,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the company. Savvy Advisors Inc. grew its holdings in shares of Zoetis by 54.0% in the second quarter. Savvy Advisors Inc. now owns 3,177 shares of the company’s stock valued at $495,000 after purchasing an additional 1,114 shares in the last quarter. Sound Income Strategies LLC lifted its position in Zoetis by 54.3% during the second quarter. Sound Income Strategies LLC now owns 432 shares of the company’s stock valued at $67,000 after purchasing an additional 152 shares during the last quarter. Canoe Financial LP grew its stake in shares of Zoetis by 859.0% in the 2nd quarter. Canoe Financial LP now owns 13,369 shares of the company’s stock worth $2,085,000 after buying an additional 11,975 shares in the last quarter. Strs Ohio bought a new stake in shares of Zoetis in the 1st quarter worth about $22,891,000. Finally, Consolidated Investment Group LLC increased its holdings in shares of Zoetis by 59.6% in the 2nd quarter. Consolidated Investment Group LLC now owns 26,235 shares of the company’s stock worth $4,091,000 after buying an additional 9,800 shares during the last quarter. 92.80% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently commented on ZTS. Piper Sandler lifted their price target on Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a research report on Monday, August 11th. JPMorgan Chase & Co. lowered their price objective on Zoetis from $230.00 to $200.00 and set an “overweight” rating for the company in a research note on Wednesday, November 5th. Morgan Stanley cut their target price on Zoetis from $211.00 to $175.00 and set an “overweight” rating on the stock in a research report on Monday, November 10th. Argus restated a “buy” rating and set a $190.00 price target on shares of Zoetis in a report on Tuesday, September 9th. Finally, BTIG Research lowered their price target on Zoetis from $200.00 to $160.00 and set a “buy” rating for the company in a research report on Wednesday, November 12th. Six research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $178.89.

Zoetis Trading Down 0.4%

ZTS opened at $118.30 on Wednesday. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.04 and a current ratio of 1.76. The stock’s 50 day moving average price is $139.63 and its 200-day moving average price is $150.90. Zoetis Inc. has a one year low of $117.09 and a one year high of $181.85. The stock has a market cap of $52.13 billion, a price-to-earnings ratio of 20.36, a P/E/G ratio of 2.31 and a beta of 0.90.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.62 by $0.08. The firm had revenue of $2.40 billion during the quarter, compared to analyst estimates of $2.42 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.Zoetis’s quarterly revenue was up .5% compared to the same quarter last year. During the same period last year, the company earned $1.58 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, equities analysts forecast that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 2nd. Stockholders of record on Friday, October 31st will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend is Friday, October 31st. Zoetis’s payout ratio is currently 33.67%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.